Pluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation Authority

By Merav Burstein | October 28, 2024

HAIFA, Israel – October 28, 2024 – Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) (“Pluri” or the “Company”), a leading biotechnology company that transforms cells into solutions, today announced that the Israel Innovation Authority (“IIA”) will fund Pluri’s collaboration with the Bar-Ilan University Research and Development Company Ltd., (“BIRAD”), the commercial arm of Bar-Ilan University, to support the continued…

Read More

A New Hero in the Fight Against Cancer

By Merav Burstein | October 6, 2024

The innovative imaging technique that could change the game in our battle against this formidable foe: copper. A fascinating discovery is set to revolutionize cancer detection and treatment. Professor Sharon Ruthstein from the Department of Chemistry at BIU is pioneering an innovative imaging technique that could change the game in our battle against this formidable foe. Her secret weapon?…

Read More